Using anakinra for adult rheumatoid arthritis.
Kastanek
Lisa
L
D000328:Adult; D018501:Antirheumatic Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000378:metabolism; D002986:Clinical Trials as Topic; D017277:Drug Approval; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein; D012795:Sialoglycoproteins / Q000493:pharmacokinetics / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D018501:Antirheumatic Agents; C507763:IL1RN protein, human; D053590:Interleukin 1 Receptor Antagonist Protein; D012795:Sialoglycoproteins